Israeli pharmaceutical company Kamada Ltd. (KMDA) said Wednesday that it has closed its initial public offering in the United States of about 6.42 million ordinary shares at a price to the public of $9.25 per ordinary share.
All of the shares of common stock in the offering were offered by Kamada and include 837,395 shares issued pursuant to the over-allotment option granted to the underwriters, which was exercised in full.
Shares of Kamada's common stock began trading on the NASDAQ Global Select Market on May 31,
Morgan Stanley & Co. LLC and Jefferies LLC acted as the representatives of the underwriters and joint book-running managers for the offering. RBC Capital Markets, LLC and Oppenheimer & Co. Inc. acted as co-managers.
For comments and feedback contact: editorial@rttnews.com
Business News
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.